| Dr Denise Ladd, MD | |
|
2300 Ramsey Street, Va Medical Center, Fayetteville, NC 28301 | |
| (910) 488-2120 | |
| (910) 482-5162 |
| Full Name | Dr Denise Ladd |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 2300 Ramsey Street, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255321782 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | M1709 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Denise Ladd, MD 2300 Ramsey Road, 28305, Va Medical Center, Fayetteville, NC 28301 Ph: (910) 488-2120 | Dr Denise Ladd, MD 2300 Ramsey Street, Va Medical Center, Fayetteville, NC 28301 Ph: (910) 488-2120 |
News Archive
Obesity is almost at epidemic proportions; it has more than doubled in children and tripled in adolescents in the past 30 years nationwide. Rosa Cataldo, DO, MPH, Director of the Healthy Weight & Wellness Center at Stony Brook Children's Hospital, says that the most effective approach to addressing weight loss in children are lifestyle-based modifications that involve parents.
While officials in Washington, D.C., grappled with delays and red tape, two professional virus hunters raced to make thousands of tests available to detect the deadly new coronavirus sweeping the globe, hoping to stem its spread in the U.S.
Idera Pharmaceuticals, Inc. today presented data from a preclinical study evaluating the mechanism of action of a Toll-like Receptor (TLR) antagonist in a preclinical model of atherosclerosis. The presentation entitled "A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis" (abstract P259) was made by Idera scientists at the American Heart Association conference "Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions" being held April 8-10 in San Francisco, CA.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of favorable clinical data for SAR3419 in the treatment of B-cell non-Hodgkin's lymphoma (NHL).
Now, researchers at the University of Silesia in Katowice and the Poznan University of Medical Sciences in Poland recommend measures to prevent future zoonotic outbreaks. They emphasized the importance of viral surveillance and research on new viral strains as primary strategies to combat these infections.
› Verified 7 days ago
Dr. Robert Allen Clinton Jr., M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 420 Owen Dr, Fayetteville, NC 28304 Phone: 910-484-1210 Fax: 910-484-1347 | |
Dr. Manfred S Rothstein, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1308 Medical Dr, Fayetteville, NC 28304 Phone: 910-323-2227 | |
Joyce E. Carter, PARA-MEDICAL Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1404 Hope Mills Rd, Fayetteville, NC 28304 Phone: 910-286-4635 | |
Richard H Shereff, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 139 Hunter Cir, Fayetteville, NC 28304 Phone: 910-323-4888 Fax: 910-323-9005 |